연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
1961. Clinicopathological characteristics of extremely young Korean multiple myeloma patients: therapeutic implications.
Junghoon Shin, Youngil Koh, Jeonghwan Youk, Miso Kim, Byung Soo Kim, Chul Won Choi, Hwa Jung Sung, Yong Park, Sung-Soo Yoon, and Inho Kim
Korean J Intern Med. 2017 Jul;32(4):722-730. doi: 10.3904/kjim.2016.256. Epub 2017 Jun 26
Link
1960. Small RNA sequencing profiles of mir-181 and mir-221, the most relevant microRNAs in acute myeloid leukemia
Yun-Gyoo Lee, Inho Kim, Somi Oh, Dong-Yeop Shin, Youngil Koh, and Keun-Wook Lee
Korean J Intern Med. 2017 Nov 27. doi: 10.3904/kjim.2017.102
Link
1959. Analysis of adverse events associated with dasatinib and nilotinib treatments in chronic-phase chronic myeloid leukemia patients outside clinical trials.
Koung Jin Suh · Ji Yun Lee · Dong-Yeop Shin · Youngil Koh · Soo-Mee Bang · Sung-Soo Yoon · Seonyang Park · Inho Kim · Jeong-Ok Lee"
Int J Hematol. 2017 Aug;106(2):229-239. doi: 10.1007/s12185-017-2225-1. Epub 2017 Apr 4
Link
1958. Infectious complications in multiple myeloma receiving autologous stem cell transplantation in the past 10 years
Hyunkyung Park · Jeonghwan Youk · Hak Ro Kim · Youngil Koh Ji Hyun Kwon · Sung-Soo Yoon · Seonyang Park · Pyoeng Gyun Choe · Nam Joong Kim · Myoung-don Oh · Wan Beom Park · Inho Kim
Int J Hematol. 2017 Dec;106(6):801-810. doi: 10.1007/s12185-017-2313-2. Epub 2017 Aug 20
Link
1957. MicroRNA-200c increases radiosensitivity of human cancer cells with activated EGFR-associated signaling.
Koo T, Cho BJ, Kim DH, Park JM, Choi EJ, Kim HH, Lee DJ, Kim IA.
Oncotarget. 2017 Jul 3;8(39):65457-65468. doi: 10.18632/oncotarget.18924. eCollection 2017 Sep 12.
Link
1956. Increased HGF Expression Induces Resistance to c-MET Tyrosine Kinase Inhibitors in Gastric Cancer.
Ahn SY, Kim J, Kim MA, Choi J, Kim WH.
Anticancer Res. 2017 Mar;37(3):1127-1138.
Link
1955. Gastrointestinal stromal tumor of unusual phenotype after imatinib treatment: A case report and diagnostic utility of ETV1 mRNA in situ hybridization.
Jung M, Park SH, Jeon YK, Won JK, Yang HK, Kim WH.
Medicine (Baltimore). 2017 Dec;96(49):e9031. doi: 10.1097/MD.0000000000009031.
Link
1954. Optimal timing of influenza vaccination during 3-week cytotoxic chemotherapy cycles.
Keam B, Kim MK, Choi Y, Choi SJ, Choe PG, Lee KH, Kim TM, Kim TY, Oh DY, Kim DW, Im SA, Kim NJ, Heo DS, Park WB, Oh MD.
Cancer. 2017 Mar 1;123(5):841-848. doi: 10.1002/cncr.30468. Epub 2016 Dec 20.
Link
1953. Changes in programmed death-ligand 1 expression during cisplatin treatment in patients with head and neck squamous cell carcinoma.
Ock CY, Kim S, Keam B, Kim S, Ahn YO, Chung EJ, Kim JH, Kim TM, Kwon SK, Jeon YK, Jung KC, Kim DW, Wu HG, Sung MW, Heo DS.
Oncotarget. 2017 Jun 16;8(58):97920-97927. doi: 10.18632/oncotarget.18542. eCollection 2017 Nov 17.
Link
1952. The Effect of Hospice Consultation on Aggressive Treatment of Lung Cancer.
Yoo SH, Keam B, Kim M, Kim TM, Kim DW, Heo DS
Cancer Res Treat. 2017 Jul 14. doi: 10.4143/crt.2017.169. [Epub ahead of print]
Link